Patents matching “THE GOVERNMENT OF THE UNITED STATES OF AMERICA”

US 10898583

Harnessing quantum dots to study, visualize, and promote immune tolerance

The Government of the United States of America, as represented by the Secretary of the Navy · Granted Jan 26, 2021 · Expires Jan 21, 2041

US 10894816

Use of IL-15 to increase thymic output and to treat lymphopenia

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Jan 19, 2021 · Expires Jan 14, 2041

US 10865389

DNA vaccines against foot-and-mouth disease virus

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 15, 2020 · Expires Dec 10, 2040

US 10858633

Method for producing foot-and-mouth disease virus (FMDV) viral proteins utilizing a modified FMDV 3C protease

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 8, 2020 · Expires Dec 3, 2040

US 10858634

Vaccines and pharmaceutical compositions against foot-and-mouth disease virus

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 8, 2020 · Expires Dec 3, 2040

US 10849970

Antibody evolution immunogens

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Dec 1, 2020 · Expires Nov 26, 2040

US 10829770

Fusion proteins containing luciferase and a polypeptide of interest

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Nov 10, 2020 · Expires Nov 5, 2040

US 10828364

Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositions

THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC. OF THE DEPT. OF HEALTH AND HUMAN SERVICES · Granted Nov 10, 2020 · Expires Nov 5, 2040

US 10808225

Use of PDL1 expressing cells to convert T cells into regulatory T cells

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Oct 20, 2020 · Expires Oct 15, 2040

US 10793865

Transferrable mechanism of generating inducible, BAR domain protein-mediated bacterial outer membrane extensions

The Government of the United States of America, as represented by the Secretary of the Navy · Granted Oct 6, 2020 · Expires Oct 1, 2040

US 10780185

Multifunctional nanoparticle bioconjugates for photoacoustic-based recording of cellular membrane potential

The Government of the United States of America, as represented by the Secretary of the Navy · Granted Sep 22, 2020 · Expires Sep 17, 2040

US 10724007

Development of dengue virus vaccine components

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Jul 28, 2020 · Expires Jul 23, 2040

US 10695414

Modulation of replicative fitness by deoptimization of synonymous codons

THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jun 30, 2020 · Expires Jun 25, 2040

US 10604548

Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Mar 31, 2020 · Expires Mar 26, 2040

US 10584355

Chimpanzee adenoviral vector-based filovirus vaccines

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Mar 10, 2020 · Expires Mar 5, 2040

US 10568956

Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Feb 25, 2020 · Expires Feb 20, 2040

US 10557118

Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

US 10513542

Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Dec 24, 2019 · Expires Dec 19, 2039

US 10507187

Regenerative tissue grafts and methods of making same

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Dec 17, 2019 · Expires Dec 12, 2039

US 10494435

Human monoclonal antibodies specific for CD22

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Dec 3, 2019 · Expires Nov 28, 2039

US 10471142

Combination therapy using immunoglobulin and C1-Inhibitor

THE GOVERNMENT OF THE UNITED STATES OF AMERICA · Granted Nov 12, 2019 · Expires Nov 7, 2039

US 10449231

Compositions and methods for dengue virus chimeric constructs in vaccines

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Oct 22, 2019 · Expires Oct 17, 2039

US 10435695

Fusion protein comprising Gaussia luciferase, translation interrupter sequence, and interferon amino acid sequences

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Oct 8, 2019 · Expires Oct 3, 2039

US 10400031

Identification of antibodies specific for lyssaviruses and methods of their use

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Sep 3, 2019 · Expires Aug 29, 2039